-
Mashup Score: 8
Non-alcoholic fatty liver disease (NAFLD) is the main cause of chronic liver disease worldwide, affecting one-fourth of the world’s population. With more than half of the world’s population, the Asia-Pacific region contributed 62.6 % of liver-related fatal incidents in 2015. Currently, liver imaging …
Source: pubmed.ncbi.nlm.nih.govCategories: General Medicine News, CardiologistsTweet
-
Mashup Score: 22
Non-alcoholic fatty liver disease (NAFLD) is the main cause of chronic liver disease worldwide, affecting one-fourth of the world’s population. With more than half of the world’s population, the Asia-Pacific region contributed 62.6 % of liver-related fatal incidents in 2015. Currently, liver imaging …
Source: pubmed.ncbi.nlm.nih.govCategories: General Medicine News, CardiologistsTweet-
RT @scottisaacsmd: Metabolic pathways affected in liver disorders. #MASLD #MASH https://t.co/QXuPbAj7IN https://t.co/R1daFKq4kl
-
-
Mashup Score: 15
In combination with dietary and physical activity counselling, semaglutide was well tolerated over 52 weeks and showed clinically relevant weight loss compared with placebo at all doses.
Source: www.thelancet.comCategories: General Medicine News, CardiologistsTweet-
RT @BevTchangMD: “Microdosing” #Ozempic is 1. Evidence based 👉 https://t.co/NC4SbfhcO8 2. Necessary to best balance risks/benefits 3. Con…
-
-
Mashup Score: 15
In combination with dietary and physical activity counselling, semaglutide was well tolerated over 52 weeks and showed clinically relevant weight loss compared with placebo at all doses.
Source: www.thelancet.comCategories: General Medicine News, CardiologistsTweet-
RT @BevTchangMD: “Microdosing” #Ozempic is 1. Evidence based 👉 https://t.co/NC4SbfhcO8 2. Necessary to best balance risks/benefits 3. Con…
-
-
Mashup Score: 7JACC: Advances Expert Panel Perspective: Shared Decision-Making in Multidisciplinary Team-Based Cardiovascular Care - 24 day(s) ago
AbstractShared decision-making (SDM) and multidisciplinary team-based care delivery are recommended across several cardiology clinical practice guidelines. However, evidence for benefit and guidanc…
Source: www.jacc.orgCategories: General Medicine News, CardiologistsTweet-
@khurramn1 @DBelardoMD @DrMarthaGulati @rauldsf_santos @drpablocorral @pabeda1 @Drlipid @ErinMichos @EugeniaGianos @a_l_bailey @DrMichaelShapir @ASPCardio @Lross246 @Brian_RosePA @GiaconaJohn We have different interpretations as to risk and cholesterol levels to achieve. After #SDM, pt and I decided 70 mg/dL was reasonable given cost of OOP pcsk9i. May still consider BPA/Eze (add’l 15% from BPA) switch from Eze alone. Thx everyone! https://t.co/obhiFqImyF https://t.co/VaYqFequSh https://t.co/w49UgnIDpX
-
-
Mashup Score: 4ClinicalTrials.gov - 1 month(s) ago
Hide glossary Study record managers: refer to the Data Element Definitions if submitting registration or results information.
Source: clinicaltrials.govCategories: General Medicine News, CardiologistsTweet-
@StavrosDrakos @kewatson @DrMichaelShapir @JSpitz_MD @AHAUtah @juliekaufmann Meet with an amazing team of researchers - #STLEUIS https://t.co/Qk86Rfin1X #AHA24 https://t.co/omL4s3c7OP
-
-
Mashup Score: 3
In this episode of The APAC Recap, APAC president Laura Ross, PA-C, sits down with Viet Le, DMSc, PA-C, former APAC president, to discuss highlights from the…
Source: www.youtube.comCategories: General Medicine News, CardiologistsTweet-
Sitting down with APAC Pres @Lross246 and summing up my presentations at #CAPPLive 24' 1) Understand LDL-C goals and why! 2) There are non-statin lipid LLT 3) You can/should use statins in Liver Dz - up til' decomp cirrhosis ;) #AHA24 https://t.co/miat9bZhgQ @APAC_Cardiology
-
-
Mashup Score: 4593When We Fight, We Win - 2 month(s) ago
Grassroots supporters power our campaign. Join us today and find a volunteer opportunity near you to help elect Kamala Harris and Tim Walz.
Source: go.kamalaharris.comCategories: General Medicine News, CardiologistsTweet-
RT @KamalaHarris: Georgia, this race is going to be tight until the very end. But together, we will win. https://t.co/ZaRpcqNdUT https://t…
-
-
Mashup Score: 2FDA Panel Rejects SGLT1/2 Inhibitor for Type 1 Diabetes - 2 month(s) ago
Data too uncertain to support sotagliflozin in subset with chronic kidney disease, advisors say
Source: www.medpagetoday.comCategories: General Medicine News, CardiologistsTweet-
truly bummed by this decision from the FDA I hear from Neph/Endo/Cards - "we don't have any therapies for DMI, they are excluded from research" https://t.co/cjIZzAvEWz
-
-
Mashup Score: 5TikTok · Vietheartpa - 2 month(s) ago
Check out Vietheartpa’s video.
Source: www.tiktok.comCategories: General Medicine News, CardiologistsTweet-
As we enter #election eve, a tired trope. Credit: Thanks @paulisci #Vote for humanity. Vote for one another and FOR each other. Let’s retire hate, ignorance, bias, and bigotry. #TikTok https://t.co/CYqFIA6uCI https://t.co/TqJlvartmK
-
RT @scottisaacsmd: Metabolic pathways affected in liver disorders. #MASLD #MASH https://t.co/QXuPbAj7IN https://t.co/R1daFKq4kl